Run time: 54m

  0      0

2019 AABB Annual Meeting On-Demand


SN5-39: CT Research and Progress (RAP) Session: Natural Killer Cell Generation and Novel Applications


Oct 20, 2019 4:00pm ‐ Oct 20, 2019 5:30pm

Expiration Date: Dec 31, 2021


Credits: None available.

Standard: $25.00
Members: $20.00

Description

This session will explore novel preparation strategies and applications of Natural Killer (NK) cells, from the generation of NK cells to innovative therapeutic uses NK cell products. Innovative methods and applications of ex vivo expanded NK cells and cord blood NK cells engineered with a CAR will be discussed.

Learning Objectives:

  • Discuss biopreservation concerns and optimization, and translation into immune cell therapy/regenerative medicine manufacturing and clinical application.
  • Discuss use of human cord blood to produce NK cells engineered with a CAR to redirect specificity and enhance persistence.
  • Describe approaches to isolation and ex vivo expansion of NK cells.

Please note: Katy Rezvani, MD, PhD did not consent to be recorded; therefore, the on-demand presentation and handout have been modified accordingly.

Speaker(s):

Disclosures

  • Aby Mathew, PhD :

    BioLife Solutions, Inc.: Stock Shareholder (self-managed), Full-time/Part-time Employee

  • David McKenna, MD :

    National Cord Blood Program: DSMB I  Erytech: DSMB  I  B-MoGen Biotech: Scientific Advisory Board  I  BEST Collaborative: Team Co-Leader/Exec Comm  I  Icahn School of Medicine: Consultant  I  CIBMTR/BMT CTN: Medical Monitor  I  NIH/NEI: DSMB  I  Gamida: Clinical trial product manufacturing  I  Fate Therapeutics: Clinical trial product manufacturing  I  Intima: Clinical trial product manufacturing  I  Magenta: Clinical trial product manufacturing  I  NMDP: Donor and Patient Safety Monitoring Advisory Group  I  NIH/NHLBI: Research funding

  • Katy Rezvani, MD, PhD :

    Affimed, Pharmacyclics: Grant/Research Support (Secondary Investigators need not disclose)  I  EMD Serono; Adicet Bio; Onkimmune; Formula Pharma; Virogen: Consultant  I  SAB: Formula Pharma; Virogen, Kiadis Pharma: Membership on advisory committees or review panels, board membership, etc.

  • Thomas Spitzer, MD :

    ITB-Med: Scientific Advisory Board  I  Jazz Pharmaceuticals: Adjudication Board  I  BluebirdBio: Data Monitoring Committee  I  Janssen Pharmaceuticals: Honoraria  I  Vedanta Biosciences: Consultant

Credits Available


SN5-39: CT Research and Progress (RAP) Session: Natural Killer Cell Generation and Novel Applications Evaluation

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content